Category:Giovanni Coppola of Tarrytown NY (US)

Giovanni Coppola of Tarrytown NY (US)

Executive Summary

Giovanni Coppola of Tarrytown NY (US) is an inventor who has filed 4 patents. Their primary areas of innovation include for diseases caused by alterations of genetic material (3 patents), MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay (2 patents), Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (1 patents), and they have worked with companies such as Regeneron Pharmaceuticals, Inc. (4 patents). Their most frequent collaborators include (3 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• C12Q1/6883 (for diseases caused by alterations of genetic material): 3 patents
• C12Q2600/118 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 2 patents
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents
• A61K31/7105 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K38/465 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• C12Q1/6816 (characterised by the detection means (): 1 patents
• C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/531 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• A61K38/45 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K38/44 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• C12Y113/11052 (ENZYMES): 1 patents
• C12Y207/01151 (ENZYMES): 1 patents
• A61K48/005 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 1 patents
• A61K38/00 (Medicinal preparations containing peptides (peptides containing beta-lactam rings): 1 patents
• C12N15/861 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• A61K31/713 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
• A61P27/06 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• C12Q2600/156 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 1 patents

Companies

List of Companies

• Regeneron Pharmaceuticals, Inc.: 4 patents

Collaborators

• Aris Baras of Tarrytown NY (US) (3 collaborations)
• Kavita Praveen of Tarrytown NY (US) (2 collaborations)
• Goncalo Abecasis of Tarrytown NY (US) (2 collaborations)
• Sahar Gelfman of Tarrytown NY (US) (2 collaborations)
• Carmelo Romano of Tarrytown NY (US) (2 collaborations)
• Manuel Allen Revez Ferreira of Tarrytown NY (US) (1 collaborations)
• Lauren Gurski of Tarrytown NY (US) (1 collaborations)
• Arden Moscati of Tarrytown NY (US) (1 collaborations)
• Eli A. Stahl of Tarrytown NY (US) (1 collaborations)
• Ann Ligocki of Tarrytown NY (US) (1 collaborations)
• Santiago Mendez Huergo of Tarrytown NY (US) (1 collaborations)
• Jonathan Weyne of Tarrytown NY (US) (1 collaborations)
• Tave Van Zyl of Tarrytown NY (US) (1 collaborations)
• Rujin Wang of Tarrytown NY (US) (1 collaborations)
• Charles Miller of Tarrytown NY (US) (1 collaborations)
• Andreja Avbersek of Tarrytown NY (US) (1 collaborations)
• Sarah Wolf of Tarrytown NY (US) (1 collaborations)
• Alicia Hawes of Tarrytown NY (US) (1 collaborations)
• Vijay Kumar Manickavasagam Pounraja of Tarrytown NY (US) (1 collaborations)
• Gaurang Patel of Tarrytown NY (US) (1 collaborations)
• Ying Hu of Tarrytown NY (US) (1 collaborations)